Dyax Announces Update Regarding Regulatory Pathway for DX-88 (Ecallantide) in Hereditary Angioedema; FDA Confirms 30 Mg (RedNova)
- Conference call scheduled for 4:30 p.m. ET today - Dyax Corp. (Nasdaq:DYAX) today announced that it has received guidance in a recent meeting with the U.S.

NMT Medical Receives FDA Approval to Modify MIST II PFO Migraine Study in the United States (RedNova)
BOSTON, Aug. 31 /PRNewswire-FirstCall/ -- NMT Medical, Inc. announced today that it has received conditional approval from the U.S.

Group Says FDA, Advisory Panels Show Bias Toward Drug Approvals (Washington Post)
The panels of experts assembled by the Food and Drug Administration to advise it on whether to approve new drugs and medical devices are often biased in favor of recommending approval, according to a consumer group's analysis released yesterday.